🇺🇸 FDA
Pipeline program

LEUPRORELIN ACETATE, LETROZOLE, GVV858, LEUPRORELIN ACETATE, FULVESTRANT, GVV858, GOSERELIN, GOSERELIN

CGVV858A12101

Phase 2 small_molecule active

Quick answer

LEUPRORELIN ACETATE, LETROZOLE, GVV858, LEUPRORELIN ACETATE, FULVESTRANT, GVV858, GOSERELIN, GOSERELIN for Advanced HR+/HER- breast cancer is a Phase 2 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).

Program details

Company
Novartis Ophthalmics Europe
Indication
Advanced HR+/HER- breast cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials